|
|
||||||||
Ann Thorac Surg 1987;43:591-598
© 1987 The Society of Thoracic Surgeons
From the Minneapolis Heart Institute, Minneapolis, and the St. Paul Heart and Lung Center, St. Paul, MN
* Address reprint requests to Dr. Arom, Minneapolis Heart Institute, 920 E 28th St, Minneapolis, MN 55407
Despite the hemodynamic improvement in cardiac valve prostheses, valve-related deaths and complications have remained a substantial source of morbidity and mortality. This follow-up study was carried out in April, 1986, in a group of 816 patients who received 876 St. Jude Medical prostheses between October, 1977, and October, 1984. One hundred fifty-five patients (37%) of the 422 having aortic valve replacement (AVR) and 88 (29%) of the 300 having mitral valve replacement (MVR) had concomitant coronary artery bypass grafting, and 94 patients (12%) had miscellaneous procedures performed in addition to valve replacement. Sixty-three patients died within the operative period, an operative mortality of 7.7%. Follow-up was complete for 98% of the patients; the mean follow-up was 42 months. At that time, 87 more patients had died, a late mortality of 11.9%. There were 13 valve-related deaths (4 in the AVR group, 7 in the MVR group, and 2 in the miscellaneous group); the causes of death were thromboembolism (7), anticoagulant-related hemorrhage (2), valve thrombosis (2), prosthetic valve endocarditis (1), and perivalvular leak (1). There were 37 thromboembolic episodes (1.78/100 patient-years) and 67 anticoagulant-related hemorrhages (3.22/100 patient-years), 46% of which necessitated transfusion. The incidence of valve thrombosis was 0.6% (4 patients). Perivalvular leak and prosthetic valve endocarditis occurred in 7 patients (1.0%) and 5 patients (0.7%), respectively. Reoperation was carried out in 6 patients (0.8%), but only for perivalvular leak. There were no deaths, no complications, and no clinical evidence of malfunction of the prosthetic valve. The incidence of perivalvular leak, prosthetic valve endocarditis, and reoperation was rather low, and severe hemolysis occurred only in association with perivalvular leak. Thromboembolic phenomena and anticoagulant-related hemorrhage, however, have remained our major concern in spite of the favorable 7-year survival.
This article has been cited by other articles:
![]() |
K. Azarnoush, F. Laborde, and C. de Riberolles The Sorin Bicarbon over 15 years clinical outcomes: multicentre experience in 1704 patients Eur J Cardiothorac Surg, December 1, 2010; 38(6): 759 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Toole, M. R. Stroud, J. M. Kratz, A. J. Crumbley III, S. M. Bradley, F. A. Crawford Jr, and J. S. Ikonomidis Twenty-Five Year Experience With the St. Jude Medical Mechanical Valve Prosthesis Ann. Thorac. Surg., May 1, 2010; 89(5): 1402 - 1409. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vink, R. A. Kraaijenhagen, B. A. Hutten, R. B. A. van den Brink, B. A. de Mol, H. R. Buller, and M. Levi The optimal intensity of vitamin k antagonists in patients with mechanical heart valves: A meta-analysis J. Am. Coll. Cardiol., December 17, 2003; 42(12): 2042 - 2048. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Ikonomidis, J. M. Kratz, A. J. Crumbley III, M. R. Stroud, S. M. Bradley, R. M. Sade, and F. A. Crawford Jr Twenty-year experience with the St Jude Medical mechanical valve prosthesis J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 2022 - 2031. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Borman and C. De Riberolles Sorin Bicarbon™ bileaflet valve: a 10-year experience Eur J Cardiothorac Surg, January 1, 2003; 23(1): 86 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pruefer, M. Dahm, G. Dohmen, D. Horstkotte, R. Bergemann, and H. Oelert Intensity of oral anticoagulation after implantation of St. Jude Medical mitral or multiple valve replacement: lessons learned from GELIA (GELIA 5) Eur. Heart J. Suppl., December 1, 2001; 3(suppl_Q): Q39 - Q43. [Abstract] [PDF] |
||||
![]() |
J. L. Zellner, J. M. Kratz, A. J. Crumbley III, M. R. Stroud, S. M. Bradley, R. M. Sade, and F. A. Crawford Jr Long-term experience with the St. Jude medical valve prosthesis Ann. Thorac. Surg., October 1, 1999; 68(4): 1210 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Torregrosa, J. Gomez-Plana, F. J. Valera, J. Caffarena, J. M. Maronas, F. Garcia-Sanchez, J. Peris, R. Frias, and J. M. Caffarena Long-term clinical experience with the omnicarbon prosthetic valve Ann. Thorac. Surg., September 1, 1999; 68(3): 881 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Borman, W. G. B. Brands, L. Camilleri, M. Cotrufo, W. Daenen, I. Gandjbakhch, C. Infantes, A. Khayat, F. Laborde, A. Pellegrini, et al. Bicarbon valve - European multicenter clinical evaluation Eur J Cardiothorac Surg, June 1, 1998; 13(6): 685 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. David, V. L. Gott, L. A. Harker, G. E. Miller Jr, D. C. Naftel, A. G. G. Turpie, and C. W. Akins Mechanical Valves Ann. Thorac. Surg., November 1, 1996; 62(5): 1567 - 1570. [Full Text] |
||||
![]() |
C. W. Akins Results with mechanical cardiac valvular prostheses Ann. Thorac. Surg., December 1, 1995; 60(6): 1836 - 1844. [Abstract] [PDF] |
||||
![]() |
O. Jegaden, A. Eker, F. Delahaye, P. Montagna, J. Ossette, G. D. De Gevigney, and P. H. Mikaeloff Thromboembolic risk and late survival after mitral valve replacement with the St. Jude Medical valve Ann. Thorac. Surg., December 1, 1994; 58(6): 1721 - 1727. [Abstract] [PDF] |
||||
![]() |
C. W. Akins Mechanical cardiac valvular prostheses Ann. Thorac. Surg., July 1, 1991; 52(1): 161 - 172. [Abstract] [PDF] |
||||
![]() |
O. Isik, M. Balkanay, B. Kisacikoglu, H. Tanugur, O. Bayezid, and C. Yakut Results of 300 Bileaflet Mechanical Valve Implanatations Vascular and Endovascular Surgery, June 1, 1991; 25(5): 357 - 367. [Abstract] [PDF] |
||||
![]() |
M. J. Antunes Clinical performance of St. Jude and Medtronic-Hall prostheses: A randomized comparative study Ann. Thorac. Surg., November 1, 1990; 50(5): 743 - 747. [Abstract] [PDF] |
||||
![]() |
J. L. Vallejo, J. M. Gonzalez-Santos, J. Albertos, M. J. Riesgo, M. E. Bastida, M. J. Rico, F. Gonzalez-Diego, and R. Arcas Eight years' experience with the Medtronic-Hall valve prosthesis Ann. Thorac. Surg., September 1, 1990; 50(3): 429 - 436. [Abstract] [PDF] |
||||
![]() |
Cardiogenic Brain Embolism: The Second Report of the Cerebral Embolism Task Force Arch Neurol, July 1, 1989; 46(7): 727 - 743. [Abstract] [PDF] |
||||
![]() |
K. V. Arom, D. M. Nicoloff, T. E. Kersten, W. F. Northrup III, W. G. Lindsay, and R. W. Emery Ten years' experience with the St. Jude Medical valve prosthesis Ann. Thorac. Surg., June 1, 1989; 47(6): 831 - 837. [Abstract] [PDF] |
||||
![]() |
Y. Okita, S. Miki, K. Kusuhara, Y. Ueda, T. Tahata, Y. Tsukamoto, K. Yamanaka, and S. Shiraishi Intractable Hemolysis Caused by Perivalvular Leakage Following Mitral Valve Replacement with St. Jude Medical Prosthesis Ann. Thorac. Surg., July 1, 1988; 46(1): 89 - 92. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |